• Your shopping cart is empty!

PDF Preview

CLSI C43-A2

Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E

Clinical and Laboratory Standards Institute, 03/01/2010

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/03/2010

File Size:1 file , 2 MB

Note:This product is unavailable in Russia, Belarus

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI's library.

This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.

More CLSI standard pdf

CLSI C24

CLSI C24

Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; C24Ed4E

$103.00 $207.00

CLSI M45

CLSI M45

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Third Edition, M45Ed3EA2E

$90.00 $180.00

CLSI EP21

CLSI EP21

Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures, 2nd Edition, EP21Ed2E

$90.00 $180.00

CLSI QMS04-Ed3 (R2021)

CLSI QMS04-Ed3 (R2021)

Laboratory Design; Approved Guideline - Second Edition, QMS04Ed3E

$90.00 $180.00